Ionis Pharmaceuticals reported $159.2M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Adcock Ingram Holdings ZAR 14.68M 0 Dec/2024
Agios Pharmaceuticals USD 58.04M 57.96M Jun/2025
Alnylam Pharmaceuticals USD 130.98M 129.67M Jun/2025
Arrowhead Research USD 138.14M 137.91M Jun/2025
Astellas Pharma JPY 1.79B 101.21B Jun/2025
BioMarin Pharmaceutical USD 192M 191.81M Jun/2025
Celltrion KRW 230.8B 10.29B Mar/2025
Cspc Pharmaceutical CNY 11.03B 26.91M Dec/2024
Divis Laboratories Ltd 530M 0 Mar/2025
Exelixis USD 270.13M 269.86M Jul/2025
Halozyme Therapeutics USD 117.62M 117.5M Jun/2025
Ionis Pharmaceuticals USD 159.2M 159.04M Jun/2025
Kangmei Pharma CNY 13.86B 0 Jun/2025
Knight Therapeutics CAD 539.32M 1.63M Sep/2024
Laboratorios Farma EUR 3.24M 0 Jun/2023
Malin Corporation EUR 200K 0 Dec/2024
Medical Developments International AUD 115.01M 9.28M Dec/2024
Moderna USD 389M 388.96M Jun/2025
Neuren Pharmaceuticals AUD 165.27M 10.43M Dec/2024
Neurocrine Biosciences USD 99M 0 Jun/2025
Novartis USD 793M 0 Dec/2024
OPKO Health USD 779.78M 772.77M Jun/2025
Organigram Holdings CAD 134.02M 758.57M Jun/2025
Pfizer USD 5.68B 5.2B Jun/2025
Pharma Mar EUR 17.58M 6.64M Jun/2025
PTC Therapeutics USD 79.38M 79.3M Jun/2025
Qiagen NV USD 216.83M 214.3M Jun/2025
Regeneron Pharmaceuticals USD 106.4M 106.4M Jun/2025
Roche Holding CHF 107M 0 Jun/2024
Sarepta Therapeutics USD 97.71M 97.7M Jun/2025
Sartorius EUR 69.04M 38.2K Jun/2025
Sino Biopharmaceutical CNY 414.38M 0 Dec/2024
Tilray USD 93K 5K Nov/2024
Ultragenyx Pharmaceutical USD 96.35M 2.45M Jun/2025
Vertex Pharmaceuticals USD 256.3M 253.7M Jun/2025
Zz Pientze Pharmaceu 603.32M 0 Jun/2025